1163 A novel bispecific antibody-drug conjugate targeting PTK7 and TROP2, BCG033, demonstrates preclinical efficacy against triple-negative breast cancer xenografts

• Yi Yang,
• W Frank An,
• Chaoshe Guo,
• Chengzhang Shang,
• Gao An,
• Sufei Yao

Affiliations

Yi Yang

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

W Frank An

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Chaoshe Guo

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Chengzhang Shang

1Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Gao An

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China

Sufei Yao

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., Beijing, China